SecProbe.io

February 27, 2020
Yongsheng Liu
Chief Executive Officer
Wealthbridge Acquisition Limited
Flat A, 6/F, Block A
Tonnochy Towers
No. 272 Jaffe Road
Wanchai, Hong Kong
Re:Wealthbridge Acquisition Limited
Revised Preliminary Proxy Statement on Schedule 14A
Filed February 14, 2020
File No. 001-38799
Dear Mr. Liu:
            We have reviewed your filing and have the following comments.  In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.
            Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
            After reviewing your response to these comments, we may have additional comments.
 Unless we note otherwise, our references to prior comments are to comments in our January 30,
2020 letter.
Revised Preliminary Proxy Statement on Schedule 14A
Risk Factors
The coronavirus outbreak in China may weaken users' spending . . ., page 36
1.Your risk factor regarding the coronavirus outbreak addresses Chinese consumers’
spending momentum.  Please expand the risk factor to discuss the reasonably likely
known effects of the coronavirus on your business operations as a result of all of
Scienjoy’s employees being located in China.  To the extent material, address the
expected impact on your results of operation and financial condition for fiscal 2020.

 FirstName LastNameYongsheng Liu
 Comapany NameWealthbridge Acquisition Limited
 February 27, 2020 Page 2
 FirstName LastName
Yongsheng Liu
Wealthbridge Acquisition Limited
February 27, 2020
Page 2
The Business Combination Proposal
Wealthbridge's Board's Reasons for the Approval of the Business Combination, page 70
2.We note the revised disclosure regarding your financial advisor that you have provided in
response to prior comment 3.  Please disclose whether any compensation was received or
will be received by the financial advisor, and clarify, if true, that the financial advisor did
not recommend the amount of consideration to be paid.  Refer to Items 1015(b)(4) and (5)
of Regulation M-A.  Also, please reconcile the disclosure regarding your financial
advisor's valuation assessment with the disclosure on pages 10, 53, and 73 that the board
of directors did not obtain a fairness opinion from an unaffiliated third party on which to
base its assessment.
Directors, Executive Officers, Executive Compensation and Corporate Governance
Compensation of Officers and Directors of Scienjoy, page 157
3.Please disclose fiscal year 2019 compensation information related to Scienjoy's named
executive officers who will become executive officers of the company following the
business combination.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            You may contact Amanda Kim, Staff Accountant, at (202) 551-3241 or Stephen
Krikorian, Accounting Branch Chief, at (202) 551-3488 if you have questions regarding
comments on the financial statements and related matters. Please contact Bernard Nolan,
Attorney-Adviser, at (202) 551-6515 or, in his absence, Jan Woo, Legal Branch Chief, at (202)
551-3453 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc:       Giovanni Caruso